Document ID: chunk:federal_register_of_legislation:C2005A00140:clause:1_9
Version: federal_register_of_legislation:C2005A00140
Segment Type: clause
Provision Reference: sch 1 cl 9
Character Range: 8270–8895

9  Transition to full‑time office—Chairperson of the Pharmaceutical Benefits Advisory Committee

(1) This item applies to a person who was the Chairperson of the Pharmaceutical Benefits Advisory Committee immediately before the commencement of this item.

(2) After the commencement of this item, the person is taken to hold office as Chairperson of the Pharmaceutical Benefits Advisory Committee on a full‑time basis.

(3) Subitem (2) does not prevent the person from ceasing to hold that office.

[Minister's second reading speech made in—
House of Representatives on 14 September 2005
Senate on 12 October 2005]
(139/05)